HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 182 filers reported holding HAEMONETICS CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $561,797 | +114.4% | 7,143 | +101.6% | 0.08% | +54.7% |
| Q3 2022 | $262,000 | -46.1% | 3,543 | -54.0% | 0.05% | -27.4% |
| Q1 2022 | $486,000 | -2.8% | 7,694 | +2.6% | 0.07% | -44.3% |
| Q2 2021 | $500,000 | -2.0% | 7,500 | +31.6% | 0.13% | +17.0% |
| Q2 2020 | $510,000 | +16.2% | 5,700 | +29.5% | 0.11% | +17.9% |
| Q1 2020 | $439,000 | -50.4% | 4,400 | -42.9% | 0.10% | -37.1% |
| Q4 2019 | $885,000 | +100.7% | 7,700 | +120.0% | 0.15% | +81.9% |
| Q3 2019 | $441,000 | -39.3% | 3,500 | -51.8% | 0.08% | -44.3% |
| Q4 2018 | $726,000 | +45.5% | 7,254 | +66.6% | 0.15% | +81.7% |
| Q3 2018 | $499,000 | -62.0% | 4,354 | -70.3% | 0.08% | -72.3% |
| Q2 2018 | $1,314,000 | +99.7% | 14,654 | +62.8% | 0.30% | +77.2% |
| Q1 2018 | $658,000 | -10.8% | 9,000 | -29.1% | 0.17% | +11.3% |
| Q4 2017 | $738,000 | +83.1% | 12,700 | +26.7% | 0.15% | +50.0% |
| Q4 2016 | $403,000 | – | 10,023 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |